(1)
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS: Gilteritinib (XOSPATA ®) in Turkey. Mediterr J Hematol Infect Dis 2023, 15 (1), e2023031. https://doi.org/10.4084/MJHID.2023.031.